"Hepatitis C (HCV) treatment is not a "one size fits all".

During the past ten years, there has been a remarkable increase in the number and spectrum of medications used for the treatment of viral hepatitis infections including the hepatitis C virus infection (HCV). Still there is considerable variability among physicians in the use and duration of treatment of the currently available medications. Therefore, the current literature on the HCV therapy will be reviewed and summarized.

Use of GI tumor markers in clinical practice: a practical interpretation.

During the past two decades, there has been a remarkable increase in the availability and utility of tumor markers and tumor genetics in the diagnosis, and management of the various GI malignancies. Still, there is considerable variability among physicians in the use of followup studies following potentially curative resection of any of the GI cancers. Multiple surveillance strategies have been published at cost ranging from a few hundred to several thousand dollars per patient.

Acute pancreatitis: management update and future directions of pancreatic imaging.

Essential management points for AP are: 1. Intravenous fluids and adequate hydration are the mainstay of therapy. Antibiotics are not routinely indicated in most cases.